AMERICAN CENTURY COMPANIES INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$26,631,000
+120.6%
391,051
+3.5%
0.02%
+130.0%
Q2 2022$12,073,000
-1.1%
377,862
+7.2%
0.01%
+25.0%
Q1 2022$12,204,000
+17.9%
352,335
-0.4%
0.01%
+14.3%
Q4 2021$10,354,000
+18.8%
353,745
+3.4%
0.01%
+16.7%
Q3 2021$8,715,000
-27.3%
342,025
-0.1%
0.01%
-25.0%
Q2 2021$11,989,000
+41.7%
342,356
+64.9%
0.01%
+33.3%
Q1 2021$8,463,000
+52.9%
207,672
+62.5%
0.01%
+50.0%
Q4 2020$5,534,000
+17.6%
127,785
+49.8%
0.00%0.0%
Q3 2020$4,705,000
-21.1%
85,326
-9.7%
0.00%
-33.3%
Q2 2020$5,964,000
+15.8%
94,467
-6.3%
0.01%0.0%
Q1 2020$5,152,000
-38.9%
100,834
-4.9%
0.01%
-25.0%
Q4 2019$8,429,000
+166.0%
106,033
+62.3%
0.01%
+166.7%
Q3 2019$3,169,000
-2.0%
65,318
+6.3%
0.00%0.0%
Q2 2019$3,233,000
+29.5%
61,472
+30.3%
0.00%0.0%
Q1 2019$2,497,000
+8.8%
47,179
-15.7%
0.00%0.0%
Q4 2018$2,296,000
+2.6%
55,941
-5.0%
0.00%
+50.0%
Q3 2018$2,238,000
-16.5%
58,882
-0.7%
0.00%
-33.3%
Q2 2018$2,680,00059,3010.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders